Literature DB >> 12632689

Diabetes self-management in African Americans: an exploration of the role of fatalism.

Leonard E Egede1, Ramita J Bonadonna2.   

Abstract

PURPOSE: This study was conducted to explore the concept of fatalism in relation to diabetes self-management behavior in African Americans with type 2 diabetes.
METHODS: Participants (n = 39) were recruited from a clinic sample of African Americans with type 2 diabetes. Seven focus groups were conducted; the sessions were recorded, transcribed, and analyzed to identify themes related to fatalism and diabetes self-management. The ISAS paradigm (individual, symbols, audience, situation), a social psychology theory, provided the theoretical framework for the study.
RESULTS: Four dimensions of fatalism were identified: the meaning of diabetes, the illness experience, the individual's coping response, and the individual's religious and spiritual beliefs. For the participants in this study, fatalism seemed to characterize the nature of the interaction between the individual with diabetes and others, the meanings they attached to such interactions, and the decision to adopt an effective or ineffective diabetes self-management behavior.
CONCLUSIONS: Fatalism was associated with diabetes self-management in African Americans with diabetes and was multidimensional in this population; the construct appeared to differ conceptually from the perspective of current measures.

Entities:  

Mesh:

Year:  2003        PMID: 12632689     DOI: 10.1177/014572170302900115

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN: 0145-7217            Impact factor:   2.140


  45 in total

1.  The role of religion and spirituality in coping with type 2 diabetes: a qualitative study among Black men.

Authors:  Apophia Namageyo-Funa; Jessica Muilenburg; Mark Wilson
Journal:  J Relig Health       Date:  2015-02

2.  Fatalism, Diabetes Management Outcomes, and the Role of Religiosity.

Authors:  Vincent Berardi; John Bellettiere; Orit Nativ; Slezak Ladislav; Melbourne F Hovell; Orna Baron-Epel
Journal:  J Relig Health       Date:  2016-04

3.  Predictors of 4-year retention among African American and white community-dwelling participants in the UAB study of aging.

Authors:  Richard M Allman; Patricia Sawyer; Martha Crowther; Harry S Strothers; Timothy Turner; Mona N Fouad
Journal:  Gerontologist       Date:  2011-06

4.  Barriers and enablers to proper diabetic foot care amongst community dwellers in an Asian population: a qualitative study.

Authors:  Andrew Arjun Sayampanathan; Amit Nirmal Cuttilan; Christopher J Pearce
Journal:  Ann Transl Med       Date:  2017-06

5.  The Prevalence and Antecedents of Religious Beliefs About Health Control in the US Population: Variations by Race and Religious Background.

Authors:  R David Hayward; Neal Krause; Kenneth Pargament
Journal:  J Relig Health       Date:  2017-12

6.  Development and psychometric properties of the 12-item diabetes fatalism scale.

Authors:  Leonard E Egede; Charles Ellis
Journal:  J Gen Intern Med       Date:  2009-11-12       Impact factor: 5.128

7.  Content and frequency of writing on diabetes bulletin boards: does race make a difference?

Authors:  Siobhan Case; Valarie Jernigan; Audra Gardner; Philip Ritter; Catherine A Heaney; Kate R Lorig
Journal:  J Med Internet Res       Date:  2009-06-24       Impact factor: 5.428

8.  Rationale and design: telephone-delivered behavioral skills interventions for Blacks with Type 2 diabetes.

Authors:  Leonard E Egede; Joni L Strom; Valerie L Durkalski; Patrick D Mauldin; William P Moran
Journal:  Trials       Date:  2010-03-29       Impact factor: 2.279

9.  Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments.

Authors:  James E Aikens; John D Piette
Journal:  Diabetes Care       Date:  2008-10-13       Impact factor: 17.152

10.  Barriers to achieving glycemic targets: who omits insulin and why?

Authors:  Katie Weinger; Elizabeth A Beverly
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.